Nutrigenomics Market Size and Outlook 2031

Report Description

Forecast Period	2027-2031
Market Size (2025)	USD 1.13 Billion
CAGR (2026-2031)	11.06%
Fastest Growing Segment	Obesity
Largest Market	North America
Market Size (2031)	USD 2.12 Billion

Market Overview

The Global Nutrigenomics Market will grow from USD 1.13 Billion in 2025 to USD 2.12 Billion by 2031 at a 11.06% CAGR. Nutrigenomics is the scientific study of the interaction between nutrition and genes, specifically analyzing how individual genetic variation affects nutrient metabolism and how nutrients influence gene expression. The market's growth is fundamentally driven by the escalating global burden of chronic lifestyle-related diseases and a distinct paradigm shift towards preventative, personalized healthcare solutions. This increasing consumer demand for tailored health strategies, rather than generic advice, supports the adoption of genomic testing. According to the Council for Responsible Nutrition, in 2024, 69% of supplement users emphasized the importance of a personalized regimen when selecting their products.

Despite these robust drivers, the Global Nutrigenomics Market faces a significant impediment regarding the regulatory and ethical landscape. The absence of standardized global guidelines for genetic testing and ambiguous regulatory frameworks for direct-to-consumer services create uncertainty for providers and medical professionals. Furthermore, rigorous concerns regarding the privacy, security, and potential misuse of sensitive genetic data continue to deter widespread consumer adoption and delay the integration of nutrigenomic assessments into mainstream clinical practice.

Key Market Drivers

The surging prevalence of chronic and lifestyle-related diseases is a primary catalyst propelling the Global Nutrigenomics Market. As metabolic disorders and obesity rates climb globally, consumers are increasingly rejecting generic dietary guidelines in favor of genomic-based interventions that promise targeted disease prevention. This paradigm shift is substantiated by the urgent need to address non-communicable diseases through precise, gene-informed dietary modulation rather than reactionary medical treatments. According to the World Obesity Federation, March 2024, in the 'World Obesity Atlas 2024', projections indicate that the number of adults living with obesity will rise to 1.53 billion by 2035, underscoring the critical necessity for the preventive capabilities offered by nutrigenomic strategies.

Concurrently, the proliferation of Direct-to-Consumer genetic testing models, fortified by artificial intelligence, is democratizing access to complex genomic data. These platforms leverage advanced algorithms to translate intricate genetic markers into actionable nutrition advice, thereby bypassing traditional clinical bottlenecks and engaging users directly. This commercial expansion is evident in the strategic capital fueling key industry players to scale their technological infrastructure. For instance, according to Zoe, August 2024, in a corporate press release, the personalized nutrition company secured $15 million in additional funding to expand its AI-driven dietary assessment platform. Furthermore, the market's reach is widening through affordable biosensor technologies; according to Abbott, in 2024, the company launched its Lingo continuous glucose monitoring system for consumers at a price point of $49, significantly lowering the barrier to entry for personalized metabolic tracking.

Download Free Sample Report

Key Market Challenges

The regulatory and ethical landscape presents a critical impediment to the Global Nutrigenomics Market. The absence of standardized global guidelines creates a fragmented environment where ambiguous regulatory frameworks generate significant uncertainty for providers. This lack of clarity deters investment and delays the establishment of clinical protocols, causing medical professionals to remain hesitant about integrating nutrigenomic assessments into mainstream practice. Without a unified compliance structure, the market struggles to transition from niche direct-to-consumer offerings to accepted medical solutions.

Furthermore, rigorous concerns regarding the privacy and security of sensitive genetic data severely compromise consumer trust. The fear of data misuse and the potential for genetic discrimination act as powerful deterrents to widespread adoption. This volatile operating environment is substantiated by rising legal challenges. According to the International Association of Privacy Professionals, in 2024, the industry faced heightened scrutiny with the continued accumulation of over 50 complaints filed under the Illinois Genetic Information Privacy Act, underscoring the substantial litigation risks associated with handling genetic information. These privacy and regulatory hurdles collectively stifle consumer demand and hamper the market's overall growth potential.

Key Market Trends

The convergence of nutrigenomics with microbiome profiling and metabolomics is revolutionizing the market by shifting the focus from static genetic markers to dynamic, multi-omic health assessments. This holistic approach integrates host genetic data with gut microbial activity and metabolic outputs, allowing for highly specific nutritional interventions that address not just biological predisposition but current functional health status. Companies are aggressively capitalizing on this trend by developing comprehensive platforms that simultaneously analyze RNA sequencing and microbial gene expression to refine precision nutrition strategies. This strategic expansion is evident in recent investment activities; according to Viome, September 2024, in a corporate press release, the microbiome health science company secured $25 million in funding to launch a new diagnostic division, specifically aimed at extending its AI-driven precision nutrition ecosystem into the detection and management of chronic diseases.

Concurrently, the adoption of nutrigenomics within the athletic performance sector is surging as sports professionals seek to optimize recovery times and minimize injury risks through gene-based dietary tailoring. Sports nutritionists and elite teams are increasingly utilizing specialized genetic panels to identify individual variations affecting caffeine metabolism, inflammation responses, and micronutrient absorption, thereby replacing trial-and-error supplementation with scientifically validated protocols. This niche application is rapidly professionalizing, with testing services scaling their panel capabilities to meet the rigorous demands of high-performance athletics. For instance, according to NutraIngredients.com, March 2024, in the article 'The state of science for genomics in sports nutrition', the Chief Science Officer of Nutrigenomix confirmed that their platform now analyzes 77 key genes to provide targeted recommendations for optimizing athletic performance and recovery.

Segmental Insights

The obesity application is currently the fastest-growing segment within the global nutrigenomics market, primarily due to the rising global prevalence of weight-related health conditions. According to health data referenced by the World Health Organization, the increasing incidence of metabolic disorders has accelerated the demand for personalized dietary interventions over generic advice. This shift drives consumers toward genetic testing to identify specific hereditary predispositions regarding fat absorption and metabolism. Consequently, the development of DNA-based nutrition plans tailored for weight management has become a critical focal point for industry expansion.

Regional Insights

North America secures the leading position in the Global Nutrigenomics Market, primarily driven by the rising prevalence of lifestyle-related chronic conditions such as obesity and diabetes. This region exhibits exceptional consumer awareness regarding personalized health, fueling the widespread adoption of gene-based dietary solutions. Furthermore, the market is bolstered by robust research initiatives, such as the precision nutrition programs funded by the National Institutes of Health (NIH), which validate and accelerate industry advancements. The concentrated presence of major direct-to-consumer genetic testing companies further ensures the accessibility of these services across the United States and Canada.

Recent Developments

In October 2024, GenoPalate announced the launch of a significantly upgraded version of its Food Index Report, a core feature of its genomic nutrition platform. The enhanced report incorporated a more sophisticated algorithm and an expanded nutrient database to provide members with precise, color-coded food compatibility scores based on their genetic makeup. This product update was designed to improve the user experience by offering more comprehensive and actionable dietary guidance derived from the analysis of genetic variants. The launch underscored the company's commitment to advancing the application of genetic data for tailored dietary solutions in the Global Nutrigenomics Market.
In September 2024, Viome Life Sciences announced the launch of a new diagnostics division, supported by a successful $25 million Series D funding round. This expansion marked a significant development in the company's efforts to broaden its portfolio beyond consumer wellness products into clinical diagnostics for chronic diseases and cancer. The new capital and organizational structure were intended to accelerate the development and commercialization of the company’s mRNA-based testing technologies, which analyze gene expression in the microbiome to provide actionable health insights. This strategic move strengthened the company's position in the Global Nutrigenomics Market by bridging the gap between personalized nutrition and medical diagnostics.
In May 2024, the personalized nutrition company Zoe published breakthrough research in the journal Nature Medicine, demonstrating the efficacy of its data-driven dietary program. The study, titled "Measuring Efficacy Through Outcomes of Diet," compared the company’s personalized nutrition advice—derived from microbiome, blood fat, and blood sugar responses—against standard dietary guidelines in a randomized controlled trial. The results indicated that participants following the personalized program achieved significant improvements in cardiometabolic health markers, such as triglyceride levels, compared to the control group. This research highlighted the clinical value of precision nutrition approaches within the Global Nutrigenomics Market.
In April 2024, CCL Hospitality Group entered into a strategic partnership with Nutrigenomix, a biotechnology company specializing in genetic testing for personalized nutrition. This collaboration was designed to integrate nutrigenomic testing into the wellness services offered to residents in CCL's senior living communities. By utilizing Nutrigenomix’s genetic tests, the hospitality group aimed to provide personalized nutrition and fitness recommendations based on the residents' unique DNA profiles. The initiative allowed the organization's registered dietitians to deliver more precise, science-based dietary guidance, thereby enhancing the overall health and wellness management within the Global Nutrigenomics Market.

Key Market Players

Honeywell International Inc.
Itron, Inc.
Landis+Gyr AG
Apator S.A.
Diehl Stiftung & Co. KG
Elster Group GmbH
Xylem Inc.
Schneider Electric SE
Badger Meter, Inc.
Zenner International GmbH & Co. KG

By Product & Services	By Product	By Technique	By Application	By Region
Services (Nutrigenomics Genetic Testing) Product	Vitamins & Supplements Probiotics Prebiotics	Saliva/Buccal Swab Blood Others	Obesity Cancer Research Cardiovascular Diseases Digestive Health Others	North America Europe Asia Pacific South America Middle East & Africa

Report Scope:

In this report, the Global Nutrigenomics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Nutrigenomics Market, By Product & Services:

Services (Nutrigenomics Genetic Testing)
Product

Nutrigenomics Market, By Product:

Vitamins & Supplements
Probiotics
Prebiotics

Nutrigenomics Market, By Technique:

Saliva/Buccal Swab
Blood
Others

Nutrigenomics Market, By Application:

Obesity
Cancer Research
Cardiovascular Diseases
Digestive Health
Others

Nutrigenomics Market, By Region:

North America

United States
Canada
Mexico

Europe

France
United Kingdom
Italy
Germany
Spain

Asia Pacific

China
India
Japan
Australia
South Korea

South America

Brazil
Argentina
Colombia

Middle East & Africa

South Africa
Saudi Arabia
UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Nutrigenomics Market.

Available Customizations:

Global Nutrigenomics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Global Nutrigenomics Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

Table of content

1. Product Overview

1.1. Market Definition

1.2. Scope of the Market

1.2.1. Markets Covered

1.2.2. Years Considered for Study

1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study

2.2. Baseline Methodology

2.3. Key Industry Partners

2.4. Major Association and Secondary Sources

2.5. Forecasting Methodology

2.6. Data Triangulation & Validation

2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market

3.2. Overview of Key Market Segmentations

3.3. Overview of Key Market Players

3.4. Overview of Key Regions/Countries

3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Nutrigenomics Market Outlook

5.1. Market Size & Forecast

5.1.1. By Value

5.2. Market Share & Forecast

5.2.1. By Product & Services (Services (Nutrigenomics Genetic Testing), Product)

5.2.2. By Product (Vitamins & Supplements, Probiotics, Prebiotics)

5.2.3. By Technique (Saliva/Buccal Swab, Blood, Others)

5.2.4. By Application (Obesity, Cancer Research, Cardiovascular Diseases, Digestive Health, Others)

5.2.5. By Region

5.2.6. By Company (2025)

5.3. Market Map

6. North America Nutrigenomics Market Outlook

6.1. Market Size & Forecast

6.1.1. By Value

6.2. Market Share & Forecast

6.2.1. By Product & Services

6.2.2. By Product

6.2.3. By Technique

6.2.4. By Application

6.2.5. By Country

6.3. North America: Country Analysis

6.3.1. United States Nutrigenomics Market Outlook

6.3.1.1. Market Size & Forecast

6.3.1.1.1. By Value

6.3.1.2. Market Share & Forecast

6.3.1.2.1. By Product & Services

6.3.1.2.2. By Product

6.3.1.2.3. By Technique

6.3.1.2.4. By Application

6.3.2. Canada Nutrigenomics Market Outlook

6.3.2.1. Market Size & Forecast

6.3.2.1.1. By Value

6.3.2.2. Market Share & Forecast

6.3.2.2.1. By Product & Services

6.3.2.2.2. By Product

6.3.2.2.3. By Technique

6.3.2.2.4. By Application

6.3.3. Mexico Nutrigenomics Market Outlook

6.3.3.1. Market Size & Forecast

6.3.3.1.1. By Value

6.3.3.2. Market Share & Forecast

6.3.3.2.1. By Product & Services

6.3.3.2.2. By Product

6.3.3.2.3. By Technique

6.3.3.2.4. By Application

7. Europe Nutrigenomics Market Outlook

7.1. Market Size & Forecast

7.1.1. By Value

7.2. Market Share & Forecast

7.2.1. By Product & Services

7.2.2. By Product

7.2.3. By Technique

7.2.4. By Application

7.2.5. By Country

7.3. Europe: Country Analysis

7.3.1. Germany Nutrigenomics Market Outlook

7.3.1.1. Market Size & Forecast

7.3.1.1.1. By Value

7.3.1.2. Market Share & Forecast

7.3.1.2.1. By Product & Services

7.3.1.2.2. By Product

7.3.1.2.3. By Technique

7.3.1.2.4. By Application

7.3.2. France Nutrigenomics Market Outlook

7.3.2.1. Market Size & Forecast

7.3.2.1.1. By Value

7.3.2.2. Market Share & Forecast

7.3.2.2.1. By Product & Services

7.3.2.2.2. By Product

7.3.2.2.3. By Technique

7.3.2.2.4. By Application

7.3.3. United Kingdom Nutrigenomics Market Outlook

7.3.3.1. Market Size & Forecast

7.3.3.1.1. By Value

7.3.3.2. Market Share & Forecast

7.3.3.2.1. By Product & Services

7.3.3.2.2. By Product

7.3.3.2.3. By Technique

7.3.3.2.4. By Application

7.3.4. Italy Nutrigenomics Market Outlook

7.3.4.1. Market Size & Forecast

7.3.4.1.1. By Value

7.3.4.2. Market Share & Forecast

7.3.4.2.1. By Product & Services

7.3.4.2.2. By Product

7.3.4.2.3. By Technique

7.3.4.2.4. By Application

7.3.5. Spain Nutrigenomics Market Outlook

7.3.5.1. Market Size & Forecast

7.3.5.1.1. By Value

7.3.5.2. Market Share & Forecast

7.3.5.2.1. By Product & Services

7.3.5.2.2. By Product

7.3.5.2.3. By Technique

7.3.5.2.4. By Application

8. Asia Pacific Nutrigenomics Market Outlook

8.1. Market Size & Forecast

8.1.1. By Value

8.2. Market Share & Forecast

8.2.1. By Product & Services

8.2.2. By Product

8.2.3. By Technique

8.2.4. By Application

8.2.5. By Country

8.3. Asia Pacific: Country Analysis

8.3.1. China Nutrigenomics Market Outlook

8.3.1.1. Market Size & Forecast

8.3.1.1.1. By Value

8.3.1.2. Market Share & Forecast

8.3.1.2.1. By Product & Services

8.3.1.2.2. By Product

8.3.1.2.3. By Technique

8.3.1.2.4. By Application

8.3.2. India Nutrigenomics Market Outlook

8.3.2.1. Market Size & Forecast

8.3.2.1.1. By Value

8.3.2.2. Market Share & Forecast

8.3.2.2.1. By Product & Services

8.3.2.2.2. By Product

8.3.2.2.3. By Technique

8.3.2.2.4. By Application

8.3.3. Japan Nutrigenomics Market Outlook

8.3.3.1. Market Size & Forecast

8.3.3.1.1. By Value

8.3.3.2. Market Share & Forecast

8.3.3.2.1. By Product & Services

8.3.3.2.2. By Product

8.3.3.2.3. By Technique

8.3.3.2.4. By Application

8.3.4. South Korea Nutrigenomics Market Outlook

8.3.4.1. Market Size & Forecast

8.3.4.1.1. By Value

8.3.4.2. Market Share & Forecast

8.3.4.2.1. By Product & Services

8.3.4.2.2. By Product

8.3.4.2.3. By Technique

8.3.4.2.4. By Application

8.3.5. Australia Nutrigenomics Market Outlook

8.3.5.1. Market Size & Forecast

8.3.5.1.1. By Value

8.3.5.2. Market Share & Forecast

8.3.5.2.1. By Product & Services

8.3.5.2.2. By Product

8.3.5.2.3. By Technique

8.3.5.2.4. By Application

9. Middle East & Africa Nutrigenomics Market Outlook

9.1. Market Size & Forecast

9.1.1. By Value

9.2. Market Share & Forecast

9.2.1. By Product & Services

9.2.2. By Product

9.2.3. By Technique

9.2.4. By Application

9.2.5. By Country

9.3. Middle East & Africa: Country Analysis

9.3.1. Saudi Arabia Nutrigenomics Market Outlook

9.3.1.1. Market Size & Forecast

9.3.1.1.1. By Value

9.3.1.2. Market Share & Forecast

9.3.1.2.1. By Product & Services

9.3.1.2.2. By Product

9.3.1.2.3. By Technique

9.3.1.2.4. By Application

9.3.2. UAE Nutrigenomics Market Outlook

9.3.2.1. Market Size & Forecast

9.3.2.1.1. By Value

9.3.2.2. Market Share & Forecast

9.3.2.2.1. By Product & Services

9.3.2.2.2. By Product

9.3.2.2.3. By Technique

9.3.2.2.4. By Application

9.3.3. South Africa Nutrigenomics Market Outlook

9.3.3.1. Market Size & Forecast

9.3.3.1.1. By Value

9.3.3.2. Market Share & Forecast

9.3.3.2.1. By Product & Services

9.3.3.2.2. By Product

9.3.3.2.3. By Technique

9.3.3.2.4. By Application

10. South America Nutrigenomics Market Outlook

10.1. Market Size & Forecast

10.1.1. By Value

10.2. Market Share & Forecast

10.2.1. By Product & Services

10.2.2. By Product

10.2.3. By Technique

10.2.4. By Application

10.2.5. By Country

10.3. South America: Country Analysis

10.3.1. Brazil Nutrigenomics Market Outlook

10.3.1.1. Market Size & Forecast

10.3.1.1.1. By Value

10.3.1.2. Market Share & Forecast

10.3.1.2.1. By Product & Services

10.3.1.2.2. By Product

10.3.1.2.3. By Technique

10.3.1.2.4. By Application

10.3.2. Colombia Nutrigenomics Market Outlook

10.3.2.1. Market Size & Forecast

10.3.2.1.1. By Value

10.3.2.2. Market Share & Forecast

10.3.2.2.1. By Product & Services

10.3.2.2.2. By Product

10.3.2.2.3. By Technique

10.3.2.2.4. By Application

10.3.3. Argentina Nutrigenomics Market Outlook

10.3.3.1. Market Size & Forecast

10.3.3.1.1. By Value

10.3.3.2. Market Share & Forecast

10.3.3.2.1. By Product & Services

10.3.3.2.2. By Product

10.3.3.2.3. By Technique

10.3.3.2.4. By Application

11. Market Dynamics

11.1. Drivers

11.2. Challenges

12. Market Trends & Developments

12.1. Merger & Acquisition (If Any)

12.2. Product Launches (If Any)

12.3. Recent Developments

13. Global Nutrigenomics Market: SWOT Analysis

14. Porter's Five Forces Analysis

14.1. Competition in the Industry

14.2. Potential of New Entrants

14.3. Power of Suppliers

14.4. Power of Customers

14.5. Threat of Substitute Products

15. Competitive Landscape

15.1. Honeywell International Inc.

15.1.1. Business Overview

15.1.2. Products & Services

15.1.3. Recent Developments

15.1.4. Key Personnel

15.1.5. SWOT Analysis

15.2. Itron, Inc.

15.3. Landis+Gyr AG

15.4. Apator S.A.

15.5. Diehl Stiftung & Co. KG

15.6. Elster Group GmbH

15.7. Xylem Inc.

15.8. Schneider Electric SE

15.9. Badger Meter, Inc.

15.10. Zenner International GmbH & Co. KG

16. Strategic Recommendations

17. About Us & Disclaimer

Figures and Tables

Figure 1: Global Nutrigenomics Market Size, By Value (USD Million), 2016-2026F

Figure 2: Global Nutrigenomics Market Share, By Product & Services, By Value, 2016-2026F

Figure 3: Global Nutrigenomics Market Share, By Product, By Value, 2016-2026F

Figure 4: Global Nutrigenomics Market Share, By Technique, By Value, 2016-2026F

Figure 5: Global Nutrigenomics Market Share, By Application, By Value, 2016-2026F

Figure 6: Global Nutrigenomics Market Share, By Region, By Value, 2016-2026F

Figure 7: Global Nutrigenomics Market Share, By Company, By Value, 2020

Figure 8: Global Biochip Market Map, By Region, Market Size (USD Million) & Growth Rate (%), 2020

Figure 9: Global Biochip Market Map, By Technique, Market Size (USD Million) & Growth Rate (%), 2020

Figure 10: North America Nutrigenomics Market Size, By Value (USD Million), 2016-2026F

Figure 11: North America Nutrigenomics Market Share, By Product & Services, By Value, 2016-2026F

Figure 12: North America Nutrigenomics Market Share, By Product, By Value, 2016-2026F

Figure 13: North America Nutrigenomics Market Share, By Technique, By Value, 2016-2026F

Figure 14: North America Nutrigenomics Market Share, By Application, By Value, 2016-2026F

Figure 15: North America Nutrigenomics Market Share, By Country, By Value, 2016-2026F

Figure 16: United States Nutrigenomics Market Size, By Value (USD Million), 2016-2026F

Figure 17: United States Nutrigenomics Market Share, By Product & Services, By Value, 2016-2026F

Figure 18: United States Nutrigenomics Market Share, By Technique, By Value, 2016-2026F

Figure 19: United States Nutrigenomics Market Share, By Application, By Value, 2016-2026F

Figure 20: Canada Nutrigenomics Market Size, By Value (USD Million), 2016-2026F

Figure 21: Canada Nutrigenomics Market Share, By Product & Services, By Value, 2016-2026F

Figure 22: Canada Nutrigenomics Market Share, By Technique, By Value, 2016-2026F

Figure 23: Canada Nutrigenomics Market Share, By Application, By Value, 2016-2026F

Figure 24: Mexico Nutrigenomics Market Size, By Value (USD Million), 2016-2026F

Figure 25: Mexico Nutrigenomics Market Share, By Product & Services, By Value, 2016-2026F

Figure 26: Mexico Nutrigenomics Market Share, By Technique, By Value, 2016-2026F

Figure 27: Mexico Nutrigenomics Market Share, By Application, By Value, 2016-2026F

Figure 28: Europe Nutrigenomics Market Size, By Value (USD Million), 2016-2026F

Figure 29: Europe Nutrigenomics Market Share, By Product & Services, By Value, 2016-2026F

Figure 30: Europe Nutrigenomics Market Share, By Product, By Value, 2016-2026F

Figure 31: Europe Nutrigenomics Market Share, By Technique, By Value, 2016-2026F

Figure 32: Europe Nutrigenomics Market Share, By Application, By Value, 2016-2026F

Figure 33: Europe Nutrigenomics Market Share, By Country, By Value, 2016-2026F

Figure 34: Germany Nutrigenomics Market Size, By Value (USD Million), 2016-2026F

Figure 35: Germany Nutrigenomics Market Share, By Product & Services, By Value, 2016-2026F

Figure 36: Germany Nutrigenomics Market Share, By Technique, By Value, 2016-2026F

Figure 37: Germany Nutrigenomics Market Share, By Application, By Value, 2016-2026F

Figure 38: United Kingdom Nutrigenomics Market Size, By Value (USD Million), 2016-2026F

Figure 39: United Kingdom Nutrigenomics Market Share, By Product & Services, By Value, 2016-2026

Figure 40: United Kingdom Nutrigenomics Market Share, By Technique, By Value, 2016-2026F

Figure 41: United Kingdom Nutrigenomics Market Share, By Application, By Value, 2016-2026F

Figure 42: France Nutrigenomics Market Size, By Value (USD Million), 2016-2026F

Figure 43: France Nutrigenomics Market Share, By Product & Services, By Value, 2016-2026F

Figure 44: France Nutrigenomics Market Share, By Technique, By Value, 2016-2026F

Figure 45: France Nutrigenomics Market Share, By Application, By Value, 2016-2026F

Figure 46: Italy Nutrigenomics Market Size, By Value (USD Million), 2016-2026F

Figure 47: Italy Nutrigenomics Market Share, By Product & Services, By Value, 2016-2026F

Figure 48: Italy Nutrigenomics Market Share, By Technique, By Value, 2016-2026F

Figure 49: Italy Nutrigenomics Market Share, By Application, By Value, 2016-2026F

Figure 50: Spain Nutrigenomics Market Size, By Value (USD Million), 2016-2026F

Figure 51: Spain Nutrigenomics Market Share, By Product & Services, By Value, 2016-2026F

Figure 52: Spain Nutrigenomics Market Share, By Technique, By Value, 2016-2026F

Figure 53: Spain Nutrigenomics Market Share, By Application, By Value, 2016-2026F

Figure 54: Asia-Pacific Nutrigenomics Market Size, By Value (USD Million), 2016-2026F

Figure 55: Asia-Pacific Nutrigenomics Market Share, By Product & Services, By Value, 2016-2026F

Figure 56: Asia-Pacific Nutrigenomics Market Share, By Product, By Value, 2016-2026F

Figure 57: Asia-Pacific Nutrigenomics Market Share, By Technique, By Value, 2016-2026F

Figure 58: Asia-Pacific Nutrigenomics Market Share, By Application, By Value, 2016-2026F

Figure 59: Asia-Pacific Nutrigenomics Market Share, By Country, By Value, 2016-2026F

Figure 60: China Nutrigenomics Market Size, By Value (USD Million), 2016-2026F

Figure 61: China Nutrigenomics Market Share, By Product & Services, By Value, 2016-2026F

Figure 62: China Nutrigenomics Market Share, By Technique, By Value, 2016-2026F

Figure 63: China Nutrigenomics Market Share, By Application, By Value, 2016-2026F

Figure 64: Japan Nutrigenomics Market Size, By Value (USD Million), 2016-2026F

Figure 65: Japan Nutrigenomics Market Share, By Product & Services, By Value, 2016-2026F

Figure 66: Japan Nutrigenomics Market Share, By Technique, By Value, 2016-2026F

Figure 67: Japan Nutrigenomics Market Share, By Application, By Value, 2016-2026F

Figure 68: India Nutrigenomics Market Size, By Value (USD Million), 2016-2026F

Figure 69: India Nutrigenomics Market Share, By Product & Services, By Value, 2016-2026F

Figure 70: India Nutrigenomics Market Share, By Technique, By Value, 2016-2026F

Figure 71: India Nutrigenomics Market Share, By Application, By Value, 2016-2026F

Figure 72: Australia Nutrigenomics Market Size, By Value (USD Million), 2016-2026F

Figure 73: Australia Nutrigenomics Market Share, By Product & Services, By Value, 2016-2026F

Figure 74: Australia Nutrigenomics Market Share, By Technique, By Value, 2016-2026F

Figure 75: Australia Nutrigenomics Market Share, By Application, By Value, 2016-2026F

Figure 76: South Korea Nutrigenomics Market Size, By Value (USD Million), 2016-2026F

Figure 77: South Korea Nutrigenomics Market Share, By Product & Services, By Value, 2016-2026F

Figure 78: South Korea Nutrigenomics Market Share, By Technique, By Value, 2016-2026F

Figure 79: South Korea Nutrigenomics Market Share, By Application, By Value, 2016-2026F

Figure 80: South America Nutrigenomics Market Size, By Value (USD Million), 2016-2026F

Figure 81: South America Nutrigenomics Market Share, By Product & Services, By Value, 2016-2026F

Figure 82: South America Nutrigenomics Market Share, By Product, By Value, 2016-2026F

Figure 83: South America Nutrigenomics Market Share, By Technique, By Value, 2016-2026F

Figure 84: South America Nutrigenomics Market Share, By Application, By Value, 2016-2026F

Figure 85: South America Nutrigenomics Market Share, By Country, By Value, 2016-2026F

Figure 86: Brazil Nutrigenomics Market Size, By Value (USD Million), 2016-2026F

Figure 87: Brazil Nutrigenomics Market Share, By Product & Services, By Value, 2016-2026F

Figure 88: Brazil Nutrigenomics Market Share, By Technique, By Value, 2016-2026F

Figure 89: Brazil Nutrigenomics Market Share, By Application, By Value, 2016-2026F

Figure 90: Argentina Nutrigenomics Market Size, By Value (USD Million), 2016-2026F

Figure 91: Argentina Nutrigenomics Market Share, By Product & Services, By Value, 2016-2026F

Figure 92: Argentina Nutrigenomics Market Share, By Technique, By Value, 2016-2026F

Figure 93: Argentina Nutrigenomics Market Share, By Application, By Value, 2016-2026F

Figure 94: Colombia Nutrigenomics Market Size, By Value (USD Million), 2016-2026F

Figure 95: Colombia Nutrigenomics Market Share, By Product & Services, By Value, 2016-2026F

Figure 96: Colombia Nutrigenomics Market Share, By Technique, By Value, 2016-2026F

Figure 97: Colombia Nutrigenomics Market Share, By Application, By Value, 2016-2026F

Figure 98: Middle East & Africa Nutrigenomics Market Size, By Value (USD Million), 2016-2026F

Figure 99: Middle East & Africa Nutrigenomics Market Share, By Product & Services, By Value, 2016-2026F

Figure 100: Middle East & Africa Nutrigenomics Market Share, By Product, By Value, 2016-2026F

Figure 101: Middle East & Africa Nutrigenomics Market Share, By Technique, By Value, 2016-2026F

Figure 102: Middle East & Africa Nutrigenomics Market Share, By Application, By Value, 2016-2026F

Figure 103: Middle East & Africa Nutrigenomics Market Share, By Country, By Value, 2016-2026F

Figure 104: South Africa Nutrigenomics Market Size, By Value (USD Million), 2016-2026F

Figure 105: South Africa Nutrigenomics Market Share, By Product & Services, By Value, 2016-2026F

Figure 106: South Africa Nutrigenomics Market Share, By Technique, By Value, 2016-2026F

Figure 107: South Africa Nutrigenomics Market Share, By Application, By Value, 2016-2026F

Figure 108: Saudi Arabia Nutrigenomics Market Size, By Value (USD Million), 2016-2026F

Figure 109: Saudi Arabia Nutrigenomics Market Share, By Product & Services, By Value, 2016-2026F

Figure 110: Saudi Arabia Nutrigenomics Market Share, By Technique, By Value, 2016-2026F

Figure 111: Saudi Arabia Nutrigenomics Market Share, By Application, By Value, 2016-2026F

Figure 112: UAE Nutrigenomics Market Size, By Value (USD Million), 2016-2026F

Figure 113: UAE Nutrigenomics Market Share, By Product & Services, By Value, 2016-2026F

Figure 114: UAE Nutrigenomics Market Share, By Technique, By Value, 2016-2026F

Figure 115: UAE Nutrigenomics Market Share, By Application, By Value, 2016-2026F

Figure 116: Kuwait Nutrigenomics Market Size, By Value (USD Million), 2016-2026F

Figure 117: Kuwait Nutrigenomics Market Share, By Product & Services, By Value, 2016-2026F

Figure 118: Kuwait Nutrigenomics Market Share, By Technique, By Value, 2016-2026F

Figure 119: Kuwait Nutrigenomics Market Share, By Application, By Value, 2016-2026F

Report Description

Table of content

Figures and Tables

Frequently asked questions

What was the market size of the Global Nutrigenomics Market in 2025?

Which is the dominating region in the Global Nutrigenomics Market?

Which is the fastest growing segment in the Global Nutrigenomics Market?

What is the expected growth rate of the Global Nutrigenomics Market?